Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinacrine in sporadic Creutzfeldt-Jakob disease
NCT00183092Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2005
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quinacrine in Creutzfeldt-Jakob disease (CJD), sponsored by University of California, San Francisco. Started Apr 2005; status: completed.
02
Drugs
quinacrine
03
Conditions
Creutzfeldt-Jakob disease (CJD)
Beyond the preview
Go deeper on NCT00183092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183092.